Schedule 13G ownership disclosure

Perspective Therapeutics Inc

Common Stock, $0.001 par value · CUSIP: 46489V302

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Avidity Partners Management LP

    Shares: 2,841,024.00 · Class: 4.2%

  • Avidity Partners Management (GP) LLC

    Shares: 2,841,024.00 · Class: 4.2%

  • Avidity Capital Partners Fund (GP) LP

    Shares: 2,841,024.00 · Class: 4.2%

  • Avidity Capital Partners (GP) LLC

    Shares: 2,841,024.00 · Class: 4.2%

  • David Witzke

    Shares: 0.00 · Class: 0.0%

  • Michael Gregory

    Shares: 2,841,024.00 · Class: 4.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-001388
Form type
SCHEDULE 13G/A
Filer
Avidity Partners Management LP
CIK
CIK 1791827
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub